VA
HCAT icon

Vident Advisory’s Health Catalyst HCAT Stock Holding History

Vident Advisory’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,591
Closed -$140K – 1456
2024
Q1 		$140K Sell
18,591
-995
-5% -$9.08K ﹤0.01% 1262
2023
Q4 		$181K Buy
19,586
+2,939
+18% +$24K ﹤0.01% 1234
2023
Q3 		$168K Buy
+16,647
New +$199K 0.01% 1148

Other funds holding HCAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vident Advisory's HCAT Position: Q2 2024 in Review

Vident Advisory sold out of Health Catalyst (HCAT) in Q2 2024, closing a stake of 18,591 shares — an estimated $140K sold.

Vident Advisory first reported a position in HCAT in Q3 2023 and held it in 3 quarters. The position peaked at $181K in Q4 2023. 161 funds tracked by Wall St. Rank hold HCAT as of Q2 2024.

  • Vident Advisory reported no remaining Health Catalyst position as of Q2 2024 after selling out during the quarter.
  • Vident Advisory sold 18,591 Health Catalyst shares in Q2 2024, an estimated $140K.
  • Vident Advisory first reported a position in Health Catalyst in Q3 2023 and held it in 3 quarters.
  • Vident Advisory's Health Catalyst position peaked at $181K in Q4 2023.
  • 161 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2024.

Based on Vident Advisory's 13F filing for Q2 2024, filed 14 Aug 2024.